Perinatal mortality associated with use of uterotonics outside of Comprehensive Emergency Obstetric and Neonatal Care

a cross-sectional study

Louise T. Day, Daniel Hruschka, Felicity Mussell, Eva Jeffers, Stacy L. Saha, Shafiul Alam

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Prior studies have shown that using uterotonics to augment or induce labor before arrival at comprehensive Emergency Obstetric and Neonatal Care (CEmONC) settings (henceforth, “outside uterotonics”) may contribute to perinatal mortality in low- and middle-income countries. We estimate its effect on perinatal mortality in rural Bangladesh. Methods: Using hospital records (23986 singleton term births, Jan 1, 2009-Dec 31, 2015) from rural Bangladesh, we use a logistic regression model to estimate the increased risk of perinatal death from uterotonics administered outside a CEmONC facility. Results: Among term births (≥37 weeks gestation), the risk of perinatal death adjusted for key confounders is significantly increased among women reporting uterotonic use outside of CEmONC (OR = 3 · 0, 95 % CI = 2 · 4,3 · 7). This increased risk is particularly high for fresh stillbirths (OR = 4 · 0, 95 % CI = 3 · 0,5 · 3) and intrapartum-related causes of early neonatal deaths (birth asphyxia) (OR = 3 · 1, 95 % CI = 2 · 2,4 · 5). Conclusions: In this sample, outside uterotonic use was associated with substantially increased risk of fresh stillbirths, deaths due to birth asphyxia, and all perinatal deaths. In settings of high uterotonic use outside of controlled settings, substantial improvement in both stillbirth and early neonatal mortality may be made by reducing such use.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalReproductive Health
Volume13
Issue number1
DOIs
StatePublished - Oct 6 2016

Fingerprint

Perinatal Mortality
Obstetrics
Stillbirth
Emergencies
Cross-Sectional Studies
Term Birth
Bangladesh
Asphyxia
Logistic Models
Parturition
Hospital Records
Infant Mortality
Pregnancy
Perinatal Death
N-(3-N-(benzyloxycarbonyl)amino-1-carboxypropyl)leucyl-O-methyltyrosine N-methylamide

Keywords

  • Bangladesh
  • Child survival
  • Neonatal death
  • Perinatal mortality
  • Stillbirth
  • Under-five mortality
  • Uterotonics

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Perinatal mortality associated with use of uterotonics outside of Comprehensive Emergency Obstetric and Neonatal Care : a cross-sectional study. / Day, Louise T.; Hruschka, Daniel; Mussell, Felicity; Jeffers, Eva; Saha, Stacy L.; Alam, Shafiul.

In: Reproductive Health, Vol. 13, No. 1, 06.10.2016, p. 1-8.

Research output: Contribution to journalArticle

Day, Louise T. ; Hruschka, Daniel ; Mussell, Felicity ; Jeffers, Eva ; Saha, Stacy L. ; Alam, Shafiul. / Perinatal mortality associated with use of uterotonics outside of Comprehensive Emergency Obstetric and Neonatal Care : a cross-sectional study. In: Reproductive Health. 2016 ; Vol. 13, No. 1. pp. 1-8.
@article{18ce92ebf0e94ef389be056b27f736b0,
title = "Perinatal mortality associated with use of uterotonics outside of Comprehensive Emergency Obstetric and Neonatal Care: a cross-sectional study",
abstract = "Background: Prior studies have shown that using uterotonics to augment or induce labor before arrival at comprehensive Emergency Obstetric and Neonatal Care (CEmONC) settings (henceforth, “outside uterotonics”) may contribute to perinatal mortality in low- and middle-income countries. We estimate its effect on perinatal mortality in rural Bangladesh. Methods: Using hospital records (23986 singleton term births, Jan 1, 2009-Dec 31, 2015) from rural Bangladesh, we use a logistic regression model to estimate the increased risk of perinatal death from uterotonics administered outside a CEmONC facility. Results: Among term births (≥37 weeks gestation), the risk of perinatal death adjusted for key confounders is significantly increased among women reporting uterotonic use outside of CEmONC (OR = 3 · 0, 95 {\%} CI = 2 · 4,3 · 7). This increased risk is particularly high for fresh stillbirths (OR = 4 · 0, 95 {\%} CI = 3 · 0,5 · 3) and intrapartum-related causes of early neonatal deaths (birth asphyxia) (OR = 3 · 1, 95 {\%} CI = 2 · 2,4 · 5). Conclusions: In this sample, outside uterotonic use was associated with substantially increased risk of fresh stillbirths, deaths due to birth asphyxia, and all perinatal deaths. In settings of high uterotonic use outside of controlled settings, substantial improvement in both stillbirth and early neonatal mortality may be made by reducing such use.",
keywords = "Bangladesh, Child survival, Neonatal death, Perinatal mortality, Stillbirth, Under-five mortality, Uterotonics",
author = "Day, {Louise T.} and Daniel Hruschka and Felicity Mussell and Eva Jeffers and Saha, {Stacy L.} and Shafiul Alam",
year = "2016",
month = "10",
day = "6",
doi = "10.1186/s12978-016-0241-x",
language = "English (US)",
volume = "13",
pages = "1--8",
journal = "Reproductive Health",
issn = "1742-4755",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Perinatal mortality associated with use of uterotonics outside of Comprehensive Emergency Obstetric and Neonatal Care

T2 - a cross-sectional study

AU - Day, Louise T.

AU - Hruschka, Daniel

AU - Mussell, Felicity

AU - Jeffers, Eva

AU - Saha, Stacy L.

AU - Alam, Shafiul

PY - 2016/10/6

Y1 - 2016/10/6

N2 - Background: Prior studies have shown that using uterotonics to augment or induce labor before arrival at comprehensive Emergency Obstetric and Neonatal Care (CEmONC) settings (henceforth, “outside uterotonics”) may contribute to perinatal mortality in low- and middle-income countries. We estimate its effect on perinatal mortality in rural Bangladesh. Methods: Using hospital records (23986 singleton term births, Jan 1, 2009-Dec 31, 2015) from rural Bangladesh, we use a logistic regression model to estimate the increased risk of perinatal death from uterotonics administered outside a CEmONC facility. Results: Among term births (≥37 weeks gestation), the risk of perinatal death adjusted for key confounders is significantly increased among women reporting uterotonic use outside of CEmONC (OR = 3 · 0, 95 % CI = 2 · 4,3 · 7). This increased risk is particularly high for fresh stillbirths (OR = 4 · 0, 95 % CI = 3 · 0,5 · 3) and intrapartum-related causes of early neonatal deaths (birth asphyxia) (OR = 3 · 1, 95 % CI = 2 · 2,4 · 5). Conclusions: In this sample, outside uterotonic use was associated with substantially increased risk of fresh stillbirths, deaths due to birth asphyxia, and all perinatal deaths. In settings of high uterotonic use outside of controlled settings, substantial improvement in both stillbirth and early neonatal mortality may be made by reducing such use.

AB - Background: Prior studies have shown that using uterotonics to augment or induce labor before arrival at comprehensive Emergency Obstetric and Neonatal Care (CEmONC) settings (henceforth, “outside uterotonics”) may contribute to perinatal mortality in low- and middle-income countries. We estimate its effect on perinatal mortality in rural Bangladesh. Methods: Using hospital records (23986 singleton term births, Jan 1, 2009-Dec 31, 2015) from rural Bangladesh, we use a logistic regression model to estimate the increased risk of perinatal death from uterotonics administered outside a CEmONC facility. Results: Among term births (≥37 weeks gestation), the risk of perinatal death adjusted for key confounders is significantly increased among women reporting uterotonic use outside of CEmONC (OR = 3 · 0, 95 % CI = 2 · 4,3 · 7). This increased risk is particularly high for fresh stillbirths (OR = 4 · 0, 95 % CI = 3 · 0,5 · 3) and intrapartum-related causes of early neonatal deaths (birth asphyxia) (OR = 3 · 1, 95 % CI = 2 · 2,4 · 5). Conclusions: In this sample, outside uterotonic use was associated with substantially increased risk of fresh stillbirths, deaths due to birth asphyxia, and all perinatal deaths. In settings of high uterotonic use outside of controlled settings, substantial improvement in both stillbirth and early neonatal mortality may be made by reducing such use.

KW - Bangladesh

KW - Child survival

KW - Neonatal death

KW - Perinatal mortality

KW - Stillbirth

KW - Under-five mortality

KW - Uterotonics

UR - http://www.scopus.com/inward/record.url?scp=84991447147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991447147&partnerID=8YFLogxK

U2 - 10.1186/s12978-016-0241-x

DO - 10.1186/s12978-016-0241-x

M3 - Article

VL - 13

SP - 1

EP - 8

JO - Reproductive Health

JF - Reproductive Health

SN - 1742-4755

IS - 1

ER -